Allow developing countries to make Pfizer treatment pills

Pfizer will not receive royalties on sales in lower-income countries and said it would waive royalties in all nations included in the agreement while COVID remains a World Health Organization-designated public health emergency.

In October, another drugmaker, Merck, announced a similar deal with the Medicines Patent Pool to allow manufacturers to produce its own COVID-19 pill, molnupiravir.